SER Serina Therapeutics, Inc.

Fundamentals / CIK 0001708599 / USD

Serina Therapeutics, Inc. reported $130K in revenue and a net loss of $24.50M for the fiscal year ended December 31, 2025 (up 132.1% year over year), with a -20870.8% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open SER in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

9 fiscal years (2017 to 2025), reported in USD.

$7.22M$3.61M$0-$18.38MFY 2017 Revenue: $1.40MFY 2017 Net Income: -$6.58M2017FY 2018 Revenue: $1.40MFY 2018 Net Income: -$7.50M2018FY 2019 Revenue: $1.73MFY 2019 Net Income: -$12.15M2019FY 2020 Revenue: $361KFY 2020 Net Income: -$10.87M2020FY 2021 Revenue: $144KFY 2021 Net Income: -$8.68M2021FY 2022 Revenue: $34KFY 2022 Net Income: -$10.46M2022FY 2023 Revenue: $3.15MFY 2023 Net Income: $5.27M2023FY 2024 Revenue: $56KFY 2024 Net Income: -$11.14M2024FY 2025 Revenue: $130KFY 2025 Net Income: -$19.18M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $130K $56K $3.15M $34K $144K $361K $1.73M $1.40M $1.40M
Cost of Revenue -- -- $40K $13K $19K $26K $244K $364K $168K
Gross Profit -- -- $102K $21K $125K $335K $1.48M $1.03M $1.24M
Research & Development $13.15M $7.48M $2.39M $1.02M $1.46M $3.71M $5.90M $5.83M $5.78M
Total Operating Expenses $24.15M $17.10M $6.28M $7.00M $8.16M $10.44M $14.04M $12.28M $9.65M
Operating Income -$24.02M -$17.05M -$3.13M -$6.97M -$7.93M -$10.10M -$12.56M -$11.24M -$6.66M
EBITDA -$23.92M -$16.95M -$3.04M -- -- -$9.40M -$12.17M -$10.71M -$5.98M
Interest Expense $213K $526K $4.90M $3.33M $1.10M -- -- -- --
Income Before Tax -$19.20M -$11.21M $5.27M $10.50M $8.70M -$11.13M -$12.24M -- --
Income Tax Expense $18K $0 $0 -- -- -$150K $148K -- --
Net Income -$19.18M -$11.14M $5.27M -$10.46M -$8.68M -$10.87M -$12.15M -$7.50M -$6.58M
Basic EPS -$1.91 -$1.51 $83.10 -$12,026.38 -$285.16 -$359.55 -$409.14 -$260.37 -$260.37
Diluted EPS -$1.91 -$1.51 $25.70 -$12,026.38 -$285.16 -$359.55 -$409.14 -$260.37 -$260.37
Basic Shares Outstanding 10.2M 7.4M 63.5K 1 30.6K 30.4K 30.1K 28.2K 24.7K
Diluted Shares Outstanding 10.2M 7.4M 208.8K 1 30.6K 30.4K 30.1K 28.2K 24.7K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $125K $0 -- $130K $0 $130K $0 -$14K
Research & Development $4.63M $3.82M $3.20M $3.40M $3.65M $3.15M $2.95M $2.37M
Total Operating Expenses $7.99M $6.78M $6.28M $6.21M $6.39M $5.70M $5.86M $5.54M
Operating Income -$7.86M -$6.78M -$6.28M -$6.21M -$6.39M -$5.57M -$5.86M -$5.55M
EBITDA -$7.84M -$6.77M -$6.28M -$6.18M -$6.38M -$5.55M -$5.86M -$5.49M
Interest Expense $204K $203K $189K $198K $6.0K $9.0K $0 $17K
Income Before Tax -- -- -$6.89M -- -- -- -$4.82M --
Income Tax Expense -- -- $7.0K -- -- -- $0 --
Net Income -$7.91M -$6.36M -$6.90M -$3.34M -$4.58M -$6.45M -$4.81M -$2.74M
Basic EPS -$0.31 -$0.55 -$0.58 -- -$0.45 -$0.66 -$0.49 --
Diluted EPS -$0.31 -$0.55 -$0.58 -- -$0.45 -$0.66 -$0.49 --
Basic Shares Outstanding 25.4M 16.4M 12.0M -- 10.3M 10.0M 9.8M --
Diluted Shares Outstanding 25.4M 16.4M 12.0M -- 10.3M 10.0M 9.8M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $3.06M $3.67M $7.62M $645K $584K $527K $2.35M $6.71M $7.38M
Cash & Short-Term Investments $3.06M $3.67M $7.62M $645K $584K $527K $2.35M $6.71M $7.38M
Accounts Receivable, Net -- -- $57K $4.0K $25K $326K $363K $131K $107K
Other Current Assets $309K $77K $0 -- -- -- -- -- --
Total Current Assets $6.08M $5.68M $7.62M $2.45M $2.23M $2.28M $4.05M $7.85M $7.59M
Property, Plant & Equipment, Net $465K $501K $573K -- -- -- $1.13M $90K $129K
Intangible Assets -- -- $0 $738K $870K $1.59M $2.15M $2.71M $1.87M
Other Non-Current Assets $29K -- -- -- -- -- -- -- --
Total Non-Current Assets $871K $1.05M $1.35M $788K $920K $1.64M $3.39M $2.82M $2.04M
Total Assets $6.95M $6.72M $8.97M $3.24M $3.15M $3.92M $7.44M $10.67M $9.63M
Accounts Payable $1.93M $744K $580K $568K $193K $761K $420K $150K $75K
Deferred Revenue (Current) -- -- -- -- -- $275K $283K $317K $180K
Other Current Liabilities $337K $193K $250K $141K -- -- -- $625K $154K
Total Current Liabilities $3.56M $2.37M $1.41M $10.08M $8.97M $5.36M $3.30M $2.44M --
Long-Term Debt -- -- -- $18.12M $13.20M -- -- -- --
Deferred Revenue (Non-Current) -- -- -- -- -- $64K -- -- --
Total Non-Current Liabilities $3.42M $3.85M $3.44M $10.48M $6.06M $3.96M $1.53M $0 --
Total Liabilities $6.99M $6.22M $4.86M $20.56M $15.03M $9.32M $4.83M $2.44M $1.31M
Total Debt (incl. Leases) $377K $461K $712K $18.12M $13.20M -- $428K -- --
Common Stock $1.0K $1.0K $0 $4.0K $4.0K $4.0K $4.0K $4.0K $3.0K
Retained Earnings -$63.50M -$44.32M -$33.18M -$116.2M -$105.7M -$97.07M -$86.21M -$74.05M -$66.55M
Accumulated Other Comp. Income -$14K $0 -- -- -- $143K $69K -$2.0K $68K
Total Stockholders' Equity -$37K $641K -$32.29M -$37.78M -$11.83M -$5.12M $2.22M $7.45M $7.28M
Total Equity -$37K $508K -$32.29M -$37.78M -$11.88M -$5.40M $2.62M $8.23M $8.32M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $19.40M $23.02M $24.53M $3.06M $8.62M $6.04M $4.27M $3.67M
Cash & Short-Term Investments $19.40M $23.02M $24.53M $3.06M $8.62M $6.04M $4.27M $3.67M
Other Current Assets $107K $0 $333K $309K $170K $177K $150K $77K
Total Current Assets $20.93M $25.03M $26.47M $6.08M $11.50M $7.99M $5.75M $5.68M
Property, Plant & Equipment, Net $466K $482K $472K $465K $580K $588K $484K $501K
Other Non-Current Assets $82K -- -- $29K -- -- -- --
Total Non-Current Assets $942K $784K $825K $871K $916K $950K $977K $1.05M
Total Assets $21.87M $25.81M $27.30M $6.95M $12.41M $8.94M $6.73M $6.72M
Accounts Payable $1.34M $1.86M $2.83M $1.93M $2.73M $1.71M $1.19M $744K
Other Current Liabilities $711K $545K $456K $337K $350K $545K $185K $193K
Total Current Liabilities $4.53M $3.76M $6.34M $3.56M $8.79M $3.56M $2.35M $2.37M
Total Non-Current Liabilities $3.42M $3.32M $3.33M $3.42M $2.03M $3.73M $2.82M $3.85M
Total Liabilities $7.95M $7.08M $9.67M $6.99M $10.82M $7.29M $5.17M $6.22M
Total Debt (incl. Leases) $197K $122K $327K $377K $311K $362K $412K $461K
Common Stock $3.0K $3.0K $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K
Retained Earnings -$84.66M -$76.75M -$70.40M -$63.50M -$60.16M -$55.58M -$49.13M -$44.32M
Accumulated Other Comp. Income -$4.0K $0 -$8.0K -$14K -$4.0K -- -- $0
Total Stockholders' Equity $13.92M -- -- -$37K $1.76M $1.80M $1.70M $641K
Total Equity $13.92M $18.73M $17.63M -$37K $1.59M $1.65M $1.56M $508K

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$19.21M -$11.21M $5.27M -$10.52M -$8.69M -$10.98M -$12.38M -$7.73M -$6.64M
Depreciation & Amortization $100K $100K $90K -- -- $699K $393K $535K $682K
Stock-Based Compensation $3.79M $2.60M $25K $760K $999K $909K $1.91M $1.28M $114K
Change in Payables $1.20M -$1.66M $393K -- -- -- -- -- --
Operating Cash Flow -$17.95M -$17.14M -$2.48M -$5.94M -$7.86M -$7.82M -$10.16M -$8.00M -$6.29M
Capital Expenditure -$59K -$22K -$504K -- -- -$20K -$641K -$21K -$1.0K
Free Cash Flow -$18.01M -$17.16M -$2.98M -- -- -$7.84M -$10.80M -$8.02M -$6.29M
Investing Cash Flow -$59K -$22K -$504K -- $666K -$20K -$361K $1.33M $5.0K
Common Stock Issued -- -- -- -- $496K -- -- $5.00M $10.00M
Financing Cash Flow $17.41M $13.21M $10.07M $6.00M $7.25M $5.96M $6.26M $6.00M $13.28M
Net Change in Cash -$616K -$3.95M $7.09M $61K $57K -$1.88M -$4.25M -$668K $7.12M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$7.91M -$6.36M -$6.90M -$3.34M -$4.59M -$6.46M -$4.82M -$2.75M
Depreciation & Amortization $19K $18K $0 $24K $16K $16K $0 $56K
Stock-Based Compensation $1.07M $1.05M $1.08M $948K $999K $890K $956K $988K
Change in Payables -$473K -$967K $896K -$811K $1.04M $522K $441K -$949K
Operating Cash Flow -$5.50M -$6.68M -$4.57M -$6.03M -$3.85M -$3.75M -$4.32M -$4.59M
Capital Expenditure -$3.0K -$28K -$25K $0 -$13K -$46K $0 -$5.0K
Free Cash Flow -$5.50M -$6.71M -$4.59M -$6.03M -$3.86M -$3.80M -$4.32M -$4.59M
Investing Cash Flow -$3.0K -$28K -$25K $0 -$13K -$46K $0 -$5.0K
Common Stock Issued -- -- -- -- -- -- $4.92M --
Financing Cash Flow $1.88M $5.20M $26.06M $481K $6.44M $5.57M $4.92M $5.03M
Net Change in Cash -$3.62M -$1.50M $21.47M -$5.56M $2.58M $1.77M $595K $437K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -- -- 3.2% 61.8% 86.8% 92.8% 85.9% 73.9% 88.0%
Operating Margin -18478.5% -30442.9% -99.2% -20514.7% -5509.0% -2797.8% -726.8% -805.5% -474.6%
Net Profit Margin -14755.4% -19894.6% 167.1% -30770.6% -6024.3% -3009.7% -703.4% -537.4% -468.7%
Return on Equity (ROE) -- -1738.1% -- -- -- -- -548.0% -100.7% -90.4%
Return on Assets (ROA) -276.0% -165.7% 58.8% -322.8% -275.0% -276.8% -163.3% -70.3% -68.3%
Current Ratio 1.71x 2.40x 5.39x 0.24x 0.25x 0.43x 1.23x 3.22x --
Quick Ratio 0.86x 1.55x 5.43x 0.06x 0.07x 0.16x 0.82x 2.80x --
Debt to Equity -- 0.72x -- -- -- -- 0.19x -- --
Revenue Growth (YoY) +132.1% -98.2% +9173.5% -76.4% -60.1% -79.1% +23.8% -0.6% --
Gross Profit Growth (YoY) -- -- +385.7% -83.2% -62.7% -77.4% +43.8% -16.5% --
Net Income Growth (YoY) -- -311.4% -- -- -- -- -- -- --
EPS Growth (YoY) -- -101.8% -- -- -- -- -- -- --
5Y Revenue / Share Growth -99.9% -100.0% +0.2% +59753.6% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -- -- -- -9239.2% -20141.4% -17141.5% -40362.7% -30442.9%
Net Profit Margin -- -- -- -7377.7% -16022.4% -9685.4% -1841.2% -19894.6%
Return on Equity (ROE) -176.0% -- -- -- -1056.0% -698.7% -55.2% -1738.1%
Return on Assets (ROA) -112.0% -82.0% -77.9% -276.0% -149.7% -140.8% -14.0% -165.7%
Current Ratio 4.62x 6.65x 4.18x 1.71x 1.31x 2.24x 2.45x 2.40x
Quick Ratio 4.28x 6.12x 3.87x 0.86x 0.98x 1.70x 1.81x 1.55x
Debt to Equity 0.01x -- -- -- 0.18x 0.20x 0.24x 0.72x
Revenue Growth (YoY) -- -100.0% -- -- -100.0% +154.9% -100.0% -100.5%
Operating Income Growth (YoY) -- -- -- -- -- -- -- -2402.5%
Net Income Growth (YoY) -- -- -- -- -425.2% -223.9% -- -360.7%
EPS Growth (YoY) -- -- -- -- -108.0% -103.1% -- --
Operating Cash Flow Growth (YoY) -- -- -- -- -- -- -- -3892.6%
Source: SEC EDGAR CompanyFacts (CIK 0001708599) · from December 31, 2017 Data through September 30, 2026 · synced Nov 21, 2026, 05:03 UTC · Open in terminal